C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 4168-4177

  Platt, Jonathan J ^a   Ramanathan, Michelle L ^a   Crosbie, Robin A ^a   Anderson, John H ^a   McKee, Ruth F ^a   Horgan, Paul G ^a   McMillan, Donald C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ABDOMINAL ABSCESS; AGED; ALBUMIN BLOOD LEVEL; ANASTOMOSIS LEAKAGE; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE CARE; PREDICTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPTICEMIA; SURGICAL INFECTION;

AGED; ANASTOMOTIC LEAK; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LENGTH OF STAY; MALE; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; ROC CURVE; SURGICAL WOUND INFECTION;

EID: 84876466162     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2498-9     Document Type: Article

References (38)

1. Fujita S, Saito N, Yamada T, et al. Randomized, multicenter trial of antibiotic prophylaxis in elective colorectal surgery: single dose vs. 3 doses of a second-generation cephalosporin without metronidazole and oral antibiotics. Arch Surg. 2007;142:657-61. (Pubitemid 47080445)
2. Rovera F, Dionigi G, Boni L, et al. Infectious complications in colorectal surgery. Surg Oncol. 2007;16(Suppl. 1):S121-4.
3. Törnqvist A, Ekelund G, Forsgren A, Leandoer L, Olson S, Ur-sing J. Single dose doxycycline prophylaxis and peroperative bacteriological culture in elective colorectal surgery. Br J Surg. 1981;68:565-8. (Pubitemid 12219165)
4. Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K. Postoperative mortality and morbidity in French patients un-dergoingm colorectal surgery: results of a prospective multicenter study. Arch Surg. 2005;140:278-83. (Pubitemid 41001821)
5. Sjo O, Larsen S, Lunde O, Nesbakken A. Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis. 2009;11:733-9.
6. Edwards LD. The epidemiology of 2056 remote site infections and 1966 surgical wound infections occurring in 1865 patients: a four year study of 40, 923 operations at Rush-Presbyterian-St. Luke's Hospital, Chicago. Ann Surg. 1976;184:758-66.
7. Miki C, Inoue Y, Mohri Y, Kobayashi M, Kusunoki M. Site-specific patterns of surgical site infections and their early indicators after elective colorectal cancer surgery. Dis Colon Rectum. 2006;49:S45-52.
8. Matsuda A, Matsutani T, Sasajima K, et al. Preoperative plasma adiponectin level is a risk factor for postoperative infection following colorectal cancer surgery. J Surg Res. 2009;157:227-34.
9. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97-132.
10. Alves A, Panis Y, Pocard M, Regimbeau JM, Valleur P. Management of anastomotic leakage after nondiverted large bowel resection. J Am Coll Surg. 1999;189:554-9.
11. Petersen S, Freitag M, Hellmich G, Ludwig K. Anastomotic leakage: impact on local recurrence and survival in surgery of colorectal cancer. Int J Colorectal Dis. 1998;13:160-3. (Pubitemid 28444874)
12. Buchs NC, Gervaz P, Secic M, Bucher P, Mugnier-Konrad B, Morel P. Incidence, consequences, and risk factors for anasto-motic dehiscence after colorectal surgery: a prospective monocentric study. Int J Colorectal Dis. 2008;23:265-70.
13. Hyman N, Manchester TL, Osler T, Burns B, Cataldo PA. Anastomotic leaks after intestinal anastomosis: it's later than you think. Ann Surg. 2007;245:254-8. (Pubitemid 46148485)
14. McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg. 2005;92:1150-4. (Pubitemid 41284881)
15. Jung SH, Yu CS, Choi PW, et al. Risk factors and oncologic impact of anastomotic leakage after rectal cancer surgery. Dis Colon Rectum. 2008;51:902-8.
16. Marra F, Steffen T, Kalak N, et al. Anastomotic leakage as a risk factor for the long-term outcome after curative resection of colon cancer. Eur J Surg Oncol. 2009;35:1060-4.
17. Welsch T, Müller SA, Ulrich A, et al. C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal Dis. 2007;22:1499-507. (Pubitemid 47543342)
18. Matthiessen P, Henriksson M, Hallbook O, Grunditz E, Noren B, Arbman G. Increase of serum C-reactive protein is an early indicator of subsequent symptomatic anastomotic leakage after anterior resection. Colorectal Dis. 2008;10:75-80. (Pubitemid 350238567)
19. Kørner H, Nielsen HJ, Søreide JA, Nedrebø BS, Søreide K, Knapp JC. Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections. J Gastrointest Surg. 2009;13:1599-606.
20. Woeste G, Müller C, Bechstein WO, Wullstein C. Increased serum levels of C-reactive protein precede anastomotic leakage in colorectal surgery. World J Surg. 2010;34:140-6.
21. Ortega-Deballon P, Radais F, Facy O, et al. C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg. 2010;34:808-14.
22. Mackay GJ, Molloy RG, O'Dwyer PJ. C-reactive protein as a predictor of postoperative infective complications following elective colorectal resection. Colorectal Dis. 2011;13:583-7.
23. Warschkow R, Tarantion I, Torzewski M, Naf F, Lange J, Steffen T. Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complication after open resection of colorectal cancer: a retrospective study of 1, 187 patients. Int J Colorectal Dis. 2011;26:1405-13.
24. Ytting H, Christensen IJ, Jensenius JC, Thiel S, Nielsen HJ. Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer. Cancer Immunol Immunother. 2005;54: 265-72. (Pubitemid 40174244)
25. Carstairs V, Morris R. Deprivation and health in Scotland. Health Bull (Edinb). 1990;48:162-75.
26. Hole DJ, McArdle CS. Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg. 2002;89: 586-90. (Pubitemid 34415608)
27. Robertson EA, Zweig MH. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem. 1981;27:1569-74.
28. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-77. (Pubitemid 23118304)
29. Soreide K. Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol. 2009;62:1-5.
30. Chromik AM, Endter F, Uhl W, Thiede A, Reith HB, Mittelkötter U. Pre-emptive antibiotic treatment vs. ''standard'' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg. 2006;391:187-94. (Pubitemid 43829376)
31. Peisajovich A, Marnell L, Mold C, et al. C-reactive protein at the interface between innate immunity and inflammation. Expert Rev Clin Immunol. 2008;4:379-90. (Pubitemid 351903275)
32. Coventry BJ, Ashdown ML, Quinn MA, et al. CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? J Transl Med. 2009;7:102.
33. Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res. 2004;30:261-77. (Pubitemid 39546229)
34. SanDer LE, Sackett SD, Dierssen U, et al. Hepatic acutephase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med. 2010;207:1453-64.
35. Fietta AM, Morosini M, Passadore I, et al. Systemic inflammatory response and downmodulation of peripheral CD25 ? Foxp3 ? T-regulatory cells in patients undergoing radiofre-quency thermal ablation for lung cancer. Hum Immunol. 2009; 70:477-86.
36. Wichmann MW, Huttl TP, Winter H, et al. Immunological effects of laparoscopic vs. open colorectal surgery: a prospective clinical study. Arch Surg. 2005;140:692-7. (Pubitemid 41124008)
37. Motoyama S, Miura M, Hinai Y, et al. C-reactive protein-717C[T genetic polymorphism associates with esophagectomy-induced stress hyperglycemia. World J Surg. 2010;35:1001-7.
38. Ramos M, Khalpey Z, Lipsitz S, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008; 248:585-591.